TRCT
EDSA icon

Tower Research Capital (TRC)’s Edesa Biotech EDSA Stock Holding History

Tower Research Capital (TRC)’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.65K Sell
507
-2,047
-80% -$6.14K ﹤0.01% 4443
2025
Q4 		$3.63K Buy
2,554
+1,275
+100% +$2.5K ﹤0.01% 4337
2025
Q3 		$3.16K Sell
1,279
-1,064
-45% -$2.46K ﹤0.01% 4541
2025
Q2 		$4.76K Buy
2,343
+1,151
+97% +$2.45K ﹤0.01% 4272
2025
Q1 		$2.91K Sell
1,192
-2,246
-65% -$4.84K ﹤0.01% 4489
2024
Q4 		$5.78K Buy
3,438
+2,422
+238% +$6.74K ﹤0.01% 4244
2024
Q3 		$4.52K Sell
1,016
-1,430
-58% -$6.5K ﹤0.01% 4516
2024
Q2 		$10.5K Buy
2,446
+372
+18% +$1.66K ﹤0.01% 4147
2024
Q1 		$8.69K Buy
2,074
+510
+33% +$2.38K ﹤0.01% 3976
2023
Q4 		$7.15K Buy
1,564
+347
+29% +$1.32K ﹤0.01% 4651
2023
Q3 		$5.38K Hold
1,217
– – ﹤0.01% 4728
2023
Q2 		$6.91K Sell
1,217
-160
-12% -$1.06K ﹤0.01% 4645
2023
Q1 		$9K Buy
1,377
+456
+50% +$4.76K ﹤0.01% 4480
2022
Q4 		$14K Sell
921
-809
-47% -$6.02K ﹤0.01% 3498
2022
Q3 		$11K Buy
1,730
+1,229
+245% +$15.1K ﹤0.01% 4433
2022
Q2 		$6K Buy
501
+75
+18% +$1.1K ﹤0.01% 4916
2022
Q1 		$9K Buy
426
+380
+826% +$10.5K ﹤0.01% 4445
2021
Q4 		$2K Sell
46
-422
-90% -$20.2K ﹤0.01% 5614
2021
Q3 		$24K Buy
+468
New +$18.2K ﹤0.01% 3555
2016
Q4 		– Sell
-2
Closed -$1K – 3931
2016
Q3 		$1K Sell
2
-1
-33% -$839 ﹤0.01% 3281
2016
Q2 		$3K Sell
3
-2
-40% -$2.06K ﹤0.01% 3677
2016
Q1 		$7K Buy
+5
New +$8.75K ﹤0.01% 2351
2015
Q4 		– Hold
0
– – – 4595

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Tower Research Capital (TRC)'s EDSA Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Edesa Biotech (EDSA) stake by 80% in Q1 2026, selling an estimated $6.14K and leaving 507 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Tower Research Capital (TRC) first reported a position in EDSA in Q1 2016 and has held it in 22 quarters since. The position peaked at $24K in Q3 2021. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

  • Tower Research Capital (TRC) held 507 shares of Edesa Biotech worth $2.65K as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,047 Edesa Biotech shares in Q1 2026, an estimated $6.14K.
  • Edesa Biotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4443 holding.
  • Tower Research Capital (TRC) first reported a position in Edesa Biotech in Q1 2016 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Edesa Biotech position peaked at $24K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.